BeiGene and Springworks Therapeutics are Collaborating to Research a Combination Therapy for Advanced Solid Tumours
The companies BeiGene Ltd. and SpringWorks Therapeutics have announced that they will collaborate to research the safety and preliminary efficacy of a combination of two drugs: BeiGene’s investigational drug lifirafenib…